Panel 2:  Biotech & Healthcare

MAR 20, 8:30 PM EDT  //  MAR 21, 8:30 AM BJT

Dr. Linfa Wang
王林发

Professor in the Programmme in Emerging Infectious Diseases at Duke-NUS Medical School, Singapore.
杜克-新加坡国立大学医学院传染病学教授

Prof Wang currently serves on the WHO’s International Health Regulations Emergency Committee to discuss and provide his expertise for the ongoing COVID-19 outbreak.

Linfa%2520Wang_edited_edited.png

Dr. Yi Shi
施毅

Founder & Managing Partner of
Lilly Asia Ventures
礼来亚洲基金创始人及管理合伙人

Yi Shi is the Founder and Managing Partner of Lilly Asia Ventures, a biomedical venture capital firm with focus on China and cross-border opportunities. Prior to his current role, Yi worked at Eli Lilly and Company in business development licensing and corporate ventures. His education includes a Ph.D. in Biochemistry and a Master of Business Administration, both from Duke University.

Yi%20Shi_edited.png

Yuanchao Xie
谢远超

Marketing manager at Amgen-BeiGene
安进-百济神州公司市场主管

Yuanchao Xie is a marketing manager at Amgen. He currently works at the global marketing function to support oncology product launch in China. Prior to this role, He works in US Value Strategy & Marketing as a marketing manager with focus in in-line oncology products.

Yuanchao%20Xie_edited.jpg